Nearly all health experts will agree that the benefits of most health screening techniques are either exaggerated by the health community or misunderstood by the public. A few discounted ones are below.
Five questionable tests
- PSA testing: A PSA blood test looks for prostate-specific antigen, a protein produced by the prostate gland. High levels are associated with prostate cancer. The problem is that the association isn't always correct, and when it is, the prostate cancer isn't necessarily deadly.
- DEXA: Dual energy X-ray absorptiometry (DEXA or DXA) in a technique developed in the 1980s that measures, among many things, bone mineral density. The scans can determine bone strength and signs of osteopenia, a possible precursor to osteoporosis. Limitations abound, though. Measurements vary from scan to scan of the same person, as well as from machine to machine.
- Full-body CT scans: If you got extra cash, usually more than $1,000, you may be tempted to get a full-body CT scan to find everything wrong with you. Avoid that temptation. For the most part, these are done so poorly by purely commercial enterprises that the results are useless. The scan will definitely find something abnormal that is likely of little concern. And it could very likely miss something that is a concern.
- Home menopause test: The test measures levels of FSH, or follicle-stimulating hormone, in the urine. Not only doesn't the kit measure this well, FSH in the urine is a poor indicator of menopause status.
- Home Alzheimer's test: The home Alzheimer's test is a scratch-and-sniff test, useful according to the manufacturers because a loss of smell can be an early signs of Alzheimer's disease. There's a little truth here. Anosmia, a loss of smell, has been associated with Alzheimer's disease and Parkinson's disease. But that association seems rare; most anosmics don't have a degenerative brain disease.